More than 1 out of 10 women worldwide are diagnosed with polycystic ovary syndrome
(PCOS), the leading cause of female reproductive and metabolic dysfunction. Despite its …

Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease
characterized by clinical or laboratorial hyperandrogenism, oligo-anovulation and metabolic …

Mitochondrial injury in granulosa cells is associated with the pathogenesis of polycystic
ovary syndrome (PCOS). However, the protective effects of melatonin against mitochondrial …

Polycystic ovary syndrome (PCOS) is the most common endocrine condition in reproductive-
age women. By comprising reproductive, endocrine, metabolic and psychological features …

Polycystic ovary syndrome is a prevalent endocrinopathy involving androgen excess, and
anovulatory infertility. The disorder is also associated with many comorbidities such as …

Lifestyle, mainly dietary, interventions are first-line treatment for women with polycystic ovary
syndrome (PCOS), but the optimal diet remains undefined. We combined a …

In the last decade it has been revealed that androgens play a direct and important role in
regulating female reproductive function. Androgens mediate their actions via the androgen …

Polycystic ovary syndrome (PCOS), characterized by the androgen excess and arrest of
antral follicles, is a common endocrine disorder among women lacking specific diagnostic …

Endoplasmic reticulum (ER) stress activated in granulosa cells contributes to the
pathophysiology of polycystic ovary syndrome (PCOS). In addition, recent studies have …

Polycystic ovary syndrome (PCOS) is a common endocrinopathy that has been associated
with impaired fertility. This chapter reviews the underlying pathophysiology of PCOS and the …